BioCentury
ARTICLE | Distillery Therapeutics

Autoimmune disease

July 10, 2017 6:09 PM UTC

Patient sample and mouse studies suggest inhibiting miR-34a could help treat RA. In dendritic cells (DCs) in synovial tissue samples from patients, levels of miR-34a were higher than in DCs in periphe...

BCIQ Company Profiles

University of Glasgow

BCIQ Target Profiles

miR-34a